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AbstrAct Lung metastasectomy is considered a safe and potentially curative procedure 
despite there is not a strong evidence that metastasectomy prolongs long-term survival in 
patients with lung metastases. Moreover, the debate is open regarding the best approach for 
lung metastasectomy, video-assisted thoracic surgery versus open approach. A systematic 
review of literature to clarify what is the best approach to prolong survival in patients with 
lung metastases was performed. Our study confirms that overall survival is equivalent for 
video-assisted thoracic surgery and thoracotomy, therefore the ‘gold standard’ surgical 
treatment for lung metastases remains a point of debate. The choice of the surgical approach 
still depends more on the single center or surgeon practice than on strong scientific evidence. 
A prospective randomized trial could clarify the question.
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Lung metastasectomy is considered as a safe and potentially curative procedure despite there is 
not a strong evidence that metastasectomy truly prolongs long-term survival in patients with lung 
metastases [1].
Although in surgical practice there are several approaches to pulmonary metastasectomy 
(PM), the proper method to use is still controversial. Furthermore since the introduction of 
minimally invasive techniques, most authors prefer the classic three ports video-assisted tho-
racic surgery (VATS) approach, few favor the uniportal method, but many surgeons still use 
the standard open approach. The advantage of the open approach consists in the fact that the 
method permits to palpate the lung to discover additional small lung nodules. On the contrary 
VATS for PM remains controversial. Critics to the VATS have argued that it might not be an 
equivalent oncological operation by intention to cure as demonstrated by a prospective study 
where 22% of the nodules that could be detected by thoracotomy (TT) were missing by VATS 
[2]. Moreover, a recent study demonstrated that the incidence of the nodules that were not imaged 
pre-operatively was 36% [3].
The question that arise is obvious. Is VATS better than TT to perform lung metastasectomy? To 
answer these questions we undertook a systematic review of the literature.
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method
A systematic review was conducted according 
to Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses recommenda-
tions. The words search included: ‘pulmo-
nary metastasectomy’, ‘lung metastasectomy’, 
‘video-assisted thoracoscopic surgery’ and ‘lung 
metastasis’. The research was limited to human 
and adults. We considered all published arti-
cles from 1990 to June 2014, which reported 
on at least sufficient data on surgical outcome, 
to be eligible. The literature search was limited 
to articles in English and to primary reports. 
We evaluated the reports’ quality from the titles 
and abstracts, identified according to the pre-
defined eligibility criteria. The full text articles 
of studies that potentially met the inclusion 
criteria were reviewed to assess their definitive 
eligibility. Papers were reviewed by two of the 
authors (A Criscione and M Migliore). Exclusion 
criteria: no attempt was made to locate unpub-
lished material. Reviews and teaching articles 
which contributed no data for analysis were also 
excluded, as were case reports, small series or 
videos or articles on pediatric patients.
Results
We have found 806 articles. From these, two 
papers were meta-analysis with the intent to 
provide a more accurate comparison between 
VATS and TT for metastatic lung cancer, two 
paper were systematic analysis and a further nine 
 provided evidence to answer the questions.
meta-analysis
Two meta-analysis are available in literature. 
Dong et al. [4] analysed six retrospective stud-
ies with a total of 546 patients included. Two 
hundred and thirty-five patients were allocated 
to the VATS group, whereas 311 were allocated 
to the open TT group to evaluate their survival 
rate. The two groups did not demonstrate a sta-
tistically significant difference in the 1-, 3- and 
5-year survival rates, but there were significant 
3-year disease-free survival rate benefits with 
open TT (p = 0.04). Authors conclude that 
VATS cannot completely replace open TT, and 
advocate a large multicenter randomized trial 
comparing these surgical techniques. The paper 
of Herle et al. [5], that is available only in abstract 
form, analyzed nine studies with a total of 796 
patients. The abstract does not reports survival 
and disease free survival rates. Authors consider 
VATS as a possible alternative to open TT for 
PM with equivalent survival and recurrence free 
survival.
Systematic review
Greenwood et al. [6] analyzed seven nonrand-
omized retrospective studies. VATS metastasec-
tomy has been associated with shorter hospital 
stay, chest drainage times and low rate of perio-
perative complications. Authors noticed a lack of 
high-quality data, which makes it impossible to 
recommend any particular surgical approach in 
terms of long-term survival, and advocate further 
studies. The paper of Molnar et al. [7], analyz-
ing seven studies concluded that palpation of the 
lung is still necessary in a therapeutic metastasec-
tomy as opposed to a diagnostic p rocedure, when 
VATS is adequate.
Comparative studies
Seven papers (table 1) compare VATS versus TT 
for different tumor metastases (mostly colorectal 
and sarcoma). These studies reported in table 1 
showed no difference in 5-year survival or disease-
free survival at 3-years between the two groups. 
VATS shows that length of postoperative stay (p 
< 0.0001) and duration of chest drainage were 
significantly lower than TT group. Chao et al. 
[9] found no difference between the two group 
in terms of overall recurrences (54% TT vs 40% 
VATS; p = 0.23). Nakas et al. [13] reported dis-
ease free interval of 20 months for VATS and 29 
months for the TT group with a p = 0.72. Another 
six authors focus on missed metastases (table 2), 
and 5 of them demonstrate that many lung malig-
nant nodules would have been missed if VATS 
was used exclusively, and consequently VATS is 
considered inadequate if the intention is to resect 
all pulmonary metastases during surgery (table 2). 
On the contrary Nakas et al. [13] conclude that the 
insertion of the surgical digit is not mandatory, 
and advice to trust the radiologist’s eye.
Discussion
PM is part of the current surgical practice. The 
criteria for resection have been published [20] in 
1995 and are the following: the primary site of 
disease has to be controlled, complete resection 
of lung disease has to be feasible, absence of 
extrapulmonary metastases, the patient has to 
be able to tolerate planned procedures and no 
better alternative can be available. Predictors 
of favorable outcomes are extended disease-free 
interval (DFI), limited number of lung metasta-
ses, and completeness of resection. According to 
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results of analysis of the International Registry 
of Lung Metastases, the reported 5-year over-
all survival is 36% [21]. Colorectal and sarcoma 
PM comprise 50% of resections with a 5-year 
survival of 30–68% and 23–50%, respectively. 
The reported 5-year survival after metastasec-
tomy for melanoma ranged from 4.5 to 38%, 
and the 5-year survival ranges from 37 to 53% 
after resection of LM with renal-cell carcinoma. 
Lung metastases occur in 4–25% of patients with 
neck and head cancers, and the reported 5-year 
survival 21–59% Scanty authors report outcome 
after resection of LM in patients with esophageal, 
gastric, hepatocellular and uterine tumors [22].
There exist different techniques to perform 
LM such as posterolateral and anterior TT, that 
allows to palpate one lung, and median sternot-
omy, clamshell or hemiclamshell TT and bilateral 
TT, used when is needed to palpate both lungs. 
VATS can be performed using the classic three-
port method, two-ports or uniportal approach 
[23]. Detterbeck et al. [17] and Mineo et al. [24] 
introduced a substernal transxiphoid approach 
for bilateral lung metastasectomy.
Our data confirm that there is no agreement 
about surgical treatment of lung metastases, and 
this has been also confirmed in a recent review 
[22]. Although it is evident that TT permits to 
palpate extra nodules, benefit of survival is not 
obvious and consequently doubts can arise about 
indications to use this approach to remove pul-
monary metastases. Moreover, the role of lym-
phadenectomy remains unclear although some 
authors believe that radical lymph node dissec-
tion can add objective benefit to overall survival; 
but this view is again not supported by scientific 
evidence [25].
In this situation of uncertainty, the gold stand-
ard surgical treatment cannot be offered to our 
patients, and the surgical indications together 
with the choice of the surgical approach still 
depends more on the single center or surgeon 
practice than on a basis of strong scientific evi-
dence. Moreover, studies reporting survival rates 
of 30–50% analyze patient selected on the basis 
of good prognostic features and this represents a 
bias that can influence survival results [26]. This 
uncertainty is due to the lack of  prospective 
studies.
Returning to our main question: in case of 
uncertainly, what is the best approach? VATS 
or TT? It is obvious that in absence of proved 
long-term survival with TT, the less invasive 
approach should be used, and therefore VATS 
should be preferred. Moreover, VATS is also a 
good approach to perform lymphadenectomy. 
However in our center we perform an ‘hybrid’ 
approach that utilizes a VATS and minithoracot-
omy that permits the entire hand to palpate the 
lung. We have used this approach in 14 patients, 
and 34 wedges resection were performed with 
hospital stay of 4 days (2–9 days).
In March 2010 it has been started [27] the PM 
for Colorectal Cancer trial (PulMiCC), a pro-
spective multicenter randomized trial with the 
primary goal to establish the effective benefit 
of performing PM in patients with pulmonary 
metastasis of colorectal cancer. The trial is opened 
internationally with centers in Italy and Serbia 
table 1. papers comparing disease-free interval and overall survival between video-assisted thoracic surgery and thoracotomy 
for different tumor metastases. 
Year pts (n) VAtS (n) tt (n) DFS VAtS% DFS tt p-value Significant? OS VAtS OS tt p-value Significant? Author
2009 60 31 29 26.4 24.8 0.74 No 70.9 34 0.2 No Gossot et al. [10]
2012 143 90 53 40 54 0.23 No 51 43 0.21 No Chao et al. [9]
2008 143 72 71 34.4 21.1 0.064 No 49.3 39,5 0.047 Yes Nakajima et al. [12]
2002 20 8 12 50 42 – – 67 70 0.85 No Mutsaerts et al. [11]
1998 22 22 16 – – – – 56.4 48.6 – No Watanabe et al. [14]
2009 171 36 135 67 51 0.27 No 69.6 58.8 0.24 No Carballo et al. [8]
2009 52 25 27 20 29 0.72 No 72 80 0.75 No Nakas et al. [13]
DFS: Disease-free interval; OS: Overall survival; Pts: Patients; TT: Thoracotomy; VATS: Video-assisted thoracic surgery.  
table 2. missed metastasis: papers comparing video-assisted thoracic surgery 
versus thoracotomy. 
Year pts (n) missed 
nodules (%)
missed 
metastases (%)
missed 
malignancy (%)
Author
2014 215 36   48 Althagafi et al. [15]
2009 57 37 18   Cerfolio et al. [16]
2011 152 34   20 Cerfolio et al. [2]
2004 16 31     Detterbeck and 
Egan [17]
2014 89 41 33 36 Eckardt and Licht [18]
1996 18 78   56 McCormack et al. [19]
2009 52 2     Nakas [13]
Pt: Patient.
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[28,29]. Although the aim is to establish which 
patients take benefit from PM, between the large 
amount of prospective data of the PulMiCC trial 
will hopefully provide conclusive evidence as to 
whether the use of TT prolong survival in lung 
metastasis.
Conclusion
Our study confirms that overall survival is 
equivalent for VATS and TT, therefore the ‘gold 
standard’ surgical treatment for lung metasta-
ses remains a point of debate. Evidence is weak 
to suggest that VATS is better than TT or vice 
versa. The consensus is far to be decided as there 
are no prospective randomized trial that could 
clarify the question. Surgeons will continue to 
operate according to their practice until scien-
tific evidence will prove what the best approach 
is for LM.
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